Balfour Beatty has the bigger order book, Hill & Smith has the cleaner insider trail


Balfour Beatty has the louder headline because a record order book is easy to sell in one line. Hill & Smith is a different sort of case. The company does not need a giant single contract to matter to you. It sells the hardware and services that keep roads, utilities, and industrial sites moving, from vehicle restraint systems to street lighting columns, pipe supports, and galvanizing. That is a steadier business than the market usually gives it credit for, and it is exactly the sort of name that can look dull until the numbers and the filings start lining up.
The stock has already done some work. Hill & Smith closed at 2,930 pence in recent sessions, below the 3,220 pence 52-week high it reached on 12 August. That matters because the chair did not buy into a collapse. He bought after a strong half-year report and after the shares had already re-rated. That is a different read from a token purchase at the bottom of a drawdown. You are looking at an insider who chose to add when the market had already had time to notice the better operating backdrop.
Hill & Smith reported half-year 2026 results on 12 August, with revenue up 8% to $606.7 million and underlying operating profit of $102.9 million. Management raised full-year 2026 outlook. The detail that matters is not just the top line. US growth ran in double digits while UK conditions were softer, which is the sort of split that tells you where the business still has operating leverage and where it is fighting the macro.
That split also explains why the name sits comfortably in the current UK infrastructure conversation. Public investment, fiscal rules, and the National Wealth Fund have kept the sector in focus, and peers have been leaning on multi-year order books to justify their own reratings. Balfour Beatty has been the cleanest example of that. Morgan Sindall and Keller Group keep showing up in sector roundups because visibility still matters more than grand promises. Hill & Smith is not a pure contractor, but it benefits from the same infrastructure spend cycle without carrying quite the same project risk.
The comparison is useful because it keeps the insider buying in proportion. A chair buying after raised guidance at a business with US momentum is not the same as a director buying into a broken chart and hoping for mean reversion. Hill & Smith’s operating picture is already doing some of the work. The filing adds a second layer, and that is where the story gets interesting.
Nick Anderson, Hill & Smith’s Chair, bought 4,120 ordinary shares on 14 August 2026 at £29.216999 per share, for a total filing value of approximately EUR 140,765, euro-normalised at ingest. That is the kind of number you can read in two ways. On its own, it is not huge against a company with a market value of about EUR 2.67 billion. But it is also not a decorative purchase. It came from the chair, it came after results, and it came after the shares had already pushed toward the top of their range.
The timing matters more than the raw size. Anderson had already bought 3,750 shares in June 2026, so this was not a one-off gesture after a press release. InsiderTrades data also shows a person closely associated with Senior Independent Director Tony Quinlan bought 1,352 shares on 13 August at £29.4325 each. That is the sort of pattern you want to see if you are trying to separate a single director’s personal view from a broader board-level posture. One buy can be noise. A sequence of buys across multiple insiders is harder to dismiss, especially when the company has just told the market that trading is better than expected.
The market has not exactly ignored the setup. Hill & Smith’s shares were already sitting below the 52-week high, but not by much. That leaves you with a stock that has had a good run, a business that has just raised guidance, and a chair who still chose to add. The filing does not tell you the shares are cheap. It does tell you the chair was willing to commit fresh capital after the rerating, and that is the point worth paying attention to.
InsiderTrades data shows this is a cluster, not a lone event. Five distinct insiders have traded the name in the same direction over the past quarter, with 12 recent declarations in total. The recent list includes Nick Anderson buying on 17 August, Stephanie Quinlan buying on 14 August, Anderson buying on 14 August, Stephanie Quinlan buying on 13 August, and Anderson buying again on 7 June and 4 June. That is a steady drumbeat, not a single headline grab.
The cluster matters because it sits alongside the company’s own operating update. You do not need to overstate the point. Insiders are not omniscient, and filings are not a substitute for cash flow, margins, or order intake. But when a chair keeps buying, and a related director-level buyer shows up in the same window, the board is not acting like a group that has lost faith in the near-term outlook. That is especially relevant in a business with exposure to infrastructure spending, where the market often waits for evidence before it pays up.
Our scoring framework rewards this kind of configuration, and for good reason. The combination here is a wide cluster, a filing value that is tiny relative to market value, and repeated buying after the half-year update. The score is not the story, but it explains why this pattern screens better than a random director purchase in a sleepy name. The company is not trying to buy back credibility with one oversized trade. It is showing a sequence of smaller, aligned buys after a better-than-feared trading update.

The historical cohort for ca/board buys at mid-cap names shows a 49% win rate at T+90 and an average return of 1.22%. That is the kind of number that keeps you honest. It is not a magic edge. It is not a promise that Hill & Smith will do anything in the next three months. It is simply the historical backdrop for a similar role-and-size bucket, and it says these trades have been close to coin-flip territory on win rate with a modest average gain.
That is useful because it stops you from turning a board buy into a thesis by itself. Hill & Smith already has a real operating story. The insider cluster adds a second read on top of that. If the cohort had been weak, you would still have the company-specific case, but you would be less inclined to lean on the filing as confirmation. Here the bucket is mildly positive, not spectacular. That fits the tone of the trade. This is not a heroic call from the board. It is a repeated, measured vote of confidence from insiders who have seen the half-year numbers and still want more exposure.
The strategy headline is available too, but treat it as a framework check, not a promise. InsiderTrades’ live out-of-sample tokens are 0.81, 26.4, and 51.5 on the restricted EU venue universe, with the usual caveat that the window is short and single-regime. That is a screen, not a guarantee. It belongs in the background while you focus on the actual company and the actual filing.
Hill & Smith is not a pure-play contractor, and that distinction matters. It supplies infrastructure products and services, which gives it a different earnings shape from the builders and project managers that dominate the UK infrastructure conversation. Vehicle restraint systems, street lighting columns, pipe supports, and galvanizing services are not glamorous lines of business. They are the sort of products that benefit from road work, utility investment, and industrial maintenance without depending on a single megaproject to land on time.
That makes the comparison with Balfour Beatty useful but incomplete. Balfour Beatty can point to a record order book and a broad project pipeline. Hill & Smith leans more on a mix of US strength and UK resilience, with the US doing the heavy lifting in the latest half-year. That is why the raised outlook matters. It tells you management sees enough visibility to lean forward, even with softer UK conditions still in the mix. The insider buying then reads as reinforcement, not as the original thesis.
The valuation context is also less forgiving than a casual glance might suggest. The shares are below the recent high, but not by enough to call them washed out. Analyst consensus sits at Moderate Buy with a median 12-month target of 3,147 pence. That leaves some room, but not a gaping discount. In other words, the market is already giving Hill & Smith credit for the better half-year. The chair’s buying says he still sees value after that credit has been assigned.
The obvious risk is that the market has already done the easy part. Hill & Smith has rerated into a better trading update, and the shares are not sitting at distressed levels. If the US growth rate cools, or if the softer UK backdrop starts to bite harder than management expects, the stock can stall even with a friendly insider trail. A chair buying after a strong run is useful, but it is not a shield against a slower second half.
There is also a structural point. Infrastructure names can look attractive when public spending is in the headlines, then spend months waiting for that optimism to turn into actual orders, margins, or cash. Hill & Smith is somewhat insulated because of its product mix, but it is not immune to the cycle. The insider cluster helps because it suggests the board is still leaning in after the update. It does not solve execution risk. It does not remove the possibility that the market has already priced in the good news.
So the practical comparison with Balfour Beatty is this. Balfour Beatty gives you the cleaner order-book story. Hill & Smith gives you the cleaner insider trail after a raised outlook and a half-year beat. If you want the more obvious infrastructure trade, the contractor has the louder headline. If you want the name where the board keeps buying after the numbers improved, Hill & Smith is the one with the more interesting filing pattern.
The next thing to watch is whether the US double-digit growth holds up into the second half and whether the UK softness stays contained. That will tell you whether the raised outlook was conservative or merely timely. The insider buying will still matter if the stock keeps grinding higher, but the market will eventually ask for another operating update, not another RNS.
For now, the setup is straightforward. Hill & Smith has a better half-year, a raised outlook, a share price below the recent high, and a five-insider buying cluster that includes the chair’s latest purchase. Balfour Beatty may have the bigger order book story, but Hill & Smith has the more persistent insider pattern. The next test is whether the company can turn that combination into another clean trading update, and whether the shares can hold above 2,930 pence while the market waits for it.
Dig deeper: Hill & Smith PLC's full insider filing history.
This is not investment advice.
Anglo American directors bought tiny stakes as copper held near records and peers rallied. The filings matter, but only ...
Mitchells & Butlers saw four insider buys as UK pubs stay under cost pressure, with the Bank of England holding rates an...
Nine GSK executives bought shares on 11 August at 1,934.96p. Read the cluster against healthcare valuations, AstraZeneca...
Dr. Martens’ CEO and CFO bought 179 shares each as the brand holds guidance, while Burberry and JD Sports frame the sect...
Fabege’s CEO bought EUR 690,726 of stock as Swedish property stabilizes, but the stock still trails peers and the rate b...
Tikehau Capital’s latest insider buy sits inside a 63-purchase cluster, but the real question is whether the sector back...